Key result
LA size ≥4 cm is linked to a ~4-fold higher AF prevalence in rheumatic mitral disease.
Why the study?
Atrial fibrillation is common in rheumatic mitral valve disease and left atrial dilatation is a predisposing factor, but the correlation between left atrial size and AF in RMVD needed further study.
Cross-Sectional (n=52)
No
Absolute Event Rate: 77.1% vs 17.6%
p-value: p=<0.001
Left atrial size ≥ 4 cm is strongly associated with the presence of atrial fibrillation in patients with rheumatic mitral valve disease.
LA enlargement may flag higher AF likelihood in rheumatic mitral valve disease; leaves open whether size modification alters outcomes.
Aim: To study the correlation between Atrial Fibrillation (AF) and left atrial size in Rheumatic Mitral valve disease (RMVD). Background: AF is the most common sustained cardiac arrhythmia which is associated with increased cardiovascular morbidity, mortality and preventable stroke. AF is common in rheumatic heart disease (RHD) particularly mitral stenosis (MS). LA dilatation is the predisposing factor for the development of AF in RMVD. Methodology: This is a hospital based cross sectional descriptive study conducted in 52 patients who were diagnosed as RMVD clinically and echocardiographically in NGMCTH, Kohalpur between December 2018 to November 2019. Detailed history and complete clinical examination were performed. Standard 12 lead ECG and 2-D echocardiography were done. Left atrial size was measured and compared with patients in AF and with sinus rhythm. Result: The age of patients ranged from 20-76 years with the mean age of 40.33 years. Out of 52 patients 30 were in AF and 23 in sinus rhythm. Among 30 patients in AF, 27 (90%) had LA size ≥ 4 cm with mean LA size of 4.6 cm whereas among 22 patients in sinus rhythm, 14 (63.64%) had LA Size <4 cm with a mean of 3.83 cm. Conclusion: Left atrial size ≥ 4 cm is the predisposing factor for the development of AF in rheumatic mitral valve disease. Therefore, if patients in sinus rhythm who are at high risk of developing AF are identified, prophylactic anticoagulation and antiarrythmic drug might prevent AF induced embolism and exacerbation of symptoms in rheumatic mitral valve disease.
No takes yet. Share an insight, caveat, or question.
Shrestha et al. (2019) conducted a cross-sectional in Rheumatic Mitral Valve Disease (n=52). Left atrial size ≥ 4 cm vs. Left atrial size < 4 cm was evaluated on Presence of Atrial Fibrillation (p=<0.001). In patients with rheumatic mitral valve disease, left atrial size ≥ 4 cm was significantly associated with a higher prevalence of atrial fibrillation compared to left atrial size < 4 cm (77.1% vs 17.6%, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: